Verified Researcher Certificate
Active ResearchRank profile with at least one indexed scholarly output
RESEARCHER PUBLIC RESEARCH PROFILE● Verified public profile
RRK-A-5024-6266-75
Nalini Kanta Sahoo
Works54
Citations388
h-index9
i10-index7
2-year citedness1.54
Mean FWCI*1.12
Top 1%*0
Top 10%*2
ResearchRank IDRRK-A-5024-6266-75
Observed nameNalini Kanta Sahoo
ORCID0000-0002-8804-626X
Current / last-known institutionMassachusetts Institute of Technology
Research topicsAnalytical Methods in Pharmaceuticals · Biosimilars and Bioanalytical Methods · Forensic Toxicology and Drug Analysis · Analytical Chemistry and Chromatography · Advanced Drug Delivery Systems
Name variantsKanta Sahoo, Nalini, NK Sahoo, Nalini K. Sahoo, Nalini Kanta Sahoo, Nalini Kanta Sahoo Nalini, NaliniKanta Sahoo, Sahoo Nalini Kanta, Sahoo, Nalini Kanta
FULL PROFILE ANALYSIS
Nalini Kanta Sahoo - detailed research intelligence
Identity, scholarly output, impact indicators, affiliations, topics and publication evidence for this ResearchRank record.
Profile typeResearcher
Works54
Citations388
h-index9
i10-index7
Current / last-known affiliationMassachusetts Institute of Technology
ORCID0000-0002-8804-626X
Name variantsKanta Sahoo, Nalini, NK Sahoo, Nalini K. Sahoo, Nalini Kanta Sahoo, Nalini Kanta Sahoo Nalini, NaliniKanta Sahoo, Sahoo Nalini Kanta, Sahoo, Nalini Kanta
Primary research topics
Analytical Methods in PharmaceuticalsBiosimilars and Bioanalytical MethodsForensic Toxicology and Drug AnalysisAnalytical Chemistry and ChromatographyAdvanced Drug Delivery Systems
Analytical Methods in PharmaceuticalsBiosimilars and Bioanalytical MethodsForensic Toxicology and Drug AnalysisAnalytical Chemistry and ChromatographyAdvanced Drug Delivery Systems
RESEARCH ACHIEVEMENT SNAPSHOT
Evidence-backed profile highlights
This public profile presents scholarly evidence and recognition indicators without displaying certificate prices or checkout controls.
Research Output Certificate
At least 10 indexed scholarly works
Citation Impact Certificate
At least 100 indexed citations
Sustained Research Output Certificate
At least 50 indexed scholarly outputs
Top 5% Research Impact Award
Competition rank #4,572,162 of 97,603,285 in Author Global Rank; percentile position 4.6844%.
Subject Top 10% Academic Achievement Award
Competition rank #16,062 of 302,956 in Subject-wise Researcher Rank - Analytical Methods in Pharmaceuticals; percentile position 5.3018%.
Public profile: Research metrics and recognition evidence are shown for professional sharing. Commercial pricing and registration controls are intentionally omitted.
Extended publication analytics and related-profile intelligence are loading in the background. The full profile details below remain available even if the live analytics service is temporarily slow.
TOP-CITED OUTPUT
Full profile view · up to 25 leading worksResearch works
In vitro anticancer activity of Eclipta alba whole plant extract on colon cancer cell HCT-116Article · 2020 · 112 citations · Open access · FWCI 7.584 · Full text ↗
A review on controlled porosity osmotic pump tablets and its evaluationArticle · 2015 · 48 citations · Open access · FWCI 2.233 · Full text ↗
The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosisReview · 2023 · 39 citations · FWCI 1.7709 · Full text ↗
Validation of stability indicating RP-HPLC method for the estimation of mesalamine in bulk and tablet dosage formArticle · 2013 · 28 citations · FWCI 0.3165 · Full text ↗
Validation of assay indicating method development of meloxicam in bulk and some of its tablet dosage forms by RP-HPLCArticle · 2014 · 25 citations · Open access · FWCI 1.1949 · Full text ↗
Validation of assay for bulk clopidogrel and for some tablet forms by reverse-phase high-performance liquid chromatographyArticle · 2014 · 14 citations · Open access · FWCI 1.1938 · Full text ↗
Role of climate change in disasters occurrences: Forecasting and management optionsBook Chapter · 2022 · 11 citations · FWCI 4.9391 · Full text ↗
Brain tumor detection using ANFIS classifier and segmentationArticle · 2022 · 9 citations · Open access · FWCI 0.7926 · Full text ↗
Solid phase extraction and quantification of diclofenac sodium in human plasma by liquid chromatography-tandem mass spectrometryArticle · 2015 · 9 citations · FWCI 0.7815 · Full text ↗
Validation of Assay Indicating Method Development of Imatinib in Bulk and Its Capsule Dosage Form by Liquid ChromatographyArticle · 2015 · 9 citations · Open access · FWCI 0 · Full text ↗
Liposomes for the treatment of prostate cancer therapy: A reviewReview · 2024 · 8 citations · Open access · FWCI 0.2257 · Full text ↗
An overview on NMR spectroscopy based metabolomicsArticle · 2020 · 8 citations · Open access · FWCI 0.4867 · Full text ↗
validation of analytical methods a reviewReview · 2018 · 8 citations · Open access · FWCI 0 · Full text ↗
Development and Validation of Liquid Chromatography- Mass Spectroscopy/Mass Spectroscopy Method for Quantitative Analysis of Naproxen in Human Plasma after Liquid-Liquid ExtractionArticle · 2014 · 8 citations · Open access · FWCI 0.5974 · Full text ↗
Formulation and Evaluation of Orodispersible Tablets of Granisetron Hydrochloride Using Agar as Natural Super disintegrantsArticle · 2016 · 7 citations · FWCI 0.3803 · Full text ↗
Validation of Assay Indicating Method Development of Amoxicillin in Bulk and One of Its Marketed Dosage Form by RP-HPLCArticle · 2016 · 6 citations · Open access · FWCI 0.5261 · Full text ↗
Validation of Assay Indicating Method Development of Simvastatin in Bulk and its Tablet Dosage form by RP-HPLCArticle · 2014 · 6 citations · Open access · FWCI 0.5974 · Full text ↗
Development and Validation of Visible Spectroscopic Method for the Determination of Mesalamine in Bulk and Tablet FormulationArticle · 2011 · 5 citations · FWCI 0 · Full text ↗
Emerging Insights and Innovations in Acridine Derivatives: A ReviewArticle · 2025 · 4 citations · FWCI 1.1973 · Full text ↗
In vivo assessment, formulation, characterization and enhancing pharmacotherapy of encapsulated mini tablets for immediate release Sildenafil citrate and sustained release BosentanArticle · 2024 · 4 citations · Open access · FWCI 0.6972 · Full text ↗
Quantification and Validation of Simvastatin and Ezetimibe in Bulk Drugs and Combined Dosage Form by Reverse Phase Liquid Chromatographic Method (RPLC)Article · 2015 · 4 citations · FWCI 0 · Full text ↗
Degradation monitoring method development and validation of Mesalamine through characterization of degraded products using RP-HPLC and mass spectroscopyArticle · 2025 · 2 citations · Open access · FWCI 0.7558 · Full text ↗
A Review on Emerging Insights and Novel Innovations in Quinoline DerivativesArticle · 2025 · 2 citations · FWCI 0.5946 · Full text ↗
New validated LC-MS/MS simultaneous estimation of Lopinavir and Ritonavir in human plasma positive ion mode using Deuterated internal standardsPreprint · 2022 · 2 citations · Open access · Full text ↗
Development and Validation of Entacapone in Human Plasma by Liquid Chromatography-Tandem Mass SpectrometryArticle · 2015 · 2 citations · Open access · FWCI 0 · Full text ↗